SCHEMBL26558697

SCHEMBL26558697

CCCCCCCCCCCCCCCCOC(=O)OC[C@H]1OC(=O)[C@@](C)(O)[C@@H]1OC(=O)OCCCCCCCCCCCCCCCC

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
TSHR P16473 2/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 2/20 0.36
MAPT P10636 1/20 0.36
CYP2C19 P33261 1/20 0.36
NAAA Q02083 3/20 0.35
PRKCA P17252 3/20 0.34
PRKD3 O94806 1/20 0.34
PRKCG P05129 1/20 0.34
PRKCB P05771 1/20 0.34
PRKCH P24723 1/20 0.34
PRKCE Q02156 1/20 0.34
PRKCQ Q04759 1/20 0.34
PRKCD Q05655 1/20 0.34
PRKD1 Q15139 1/20 0.34
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26558167 0.91 ALDH1A1 (0.32) ALDH1A1TSHRLMNACYP3A4MAPT
SCHEMBL26558184 0.91 ALDH1A1 (0.32) ALDH1A1TSHRLMNACYP3A4MAPT
SCHEMBL26558155 0.90 TSHR (0.34) ALDH1A1TSHRLMNANAAAPRKCA
SCHEMBL26558186 0.89 TSHR (0.42) ALDH1A1TSHRLMNACYP3A4MAPT
SCHEMBL26558168 0.89 TSHR (0.42) ALDH1A1TSHRLMNACYP3A4MAPT
SCHEMBL26558170 0.88 TSHR (0.35) ALDH1A1TSHRLMNACYP3A4NAAA
SCHEMBL26558447 0.88 ALDH1A1 (0.35) ALDH1A1TSHRLMNACYP3A4MAPT
SCHEMBL26558159 0.88 TSHR (0.33) ALDH1A1TSHRLMNACYP3A4NAAA
SCHEMBL26558172 0.86 TSHR (0.36) ALDH1A1TSHRLMNACYP3A4TP53
SCHEMBL26558162 0.86 CNR1 (0.33) ALDH1A1TSHRLMNAPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331751-A1 STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES Atea Pharmaceuticals, Inc. (US) 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331751-A1 STEREOSELECTIVE MANUFACTURE OF SELECTED PURINE PHOSPHORAMIDATES NUDT1, PNP, ATIC ALDH1A1 946/4885TSHR 3475/4885LMNA 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.